The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SALVOVAR: A pragmatic randomized phase III trial comparing the salvage weekly dose-dense regimen to the standard 3-weekly regimen in patients with poor prognostic ovarian cancers (GINECO-OV130b; ENGOT-ov78).
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; Eisai; GlaxoSmithKline; Immunomedics; LEK; MSD Oncology; Myriad Genetics; Novartis; Pharma&; Roche/Genentech; Seagen; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); NOVARTIS (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech; SEAGEN
 
Nozomu Yanaihara
Consulting or Advisory Role - MSD
Speakers' Bureau - AstraZeneca/UK; Chugai Pharma; Takeda
Research Funding - Takeda
 
Gabriella Parma
Honoraria - AstraZeneca/UK; Eisai; GlaxoSmithKline; MSD; Roche
Consulting or Advisory Role - AstraZeneca/UK; Eisai; GlaxoSmithKline; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca/UK; GlaxoSmithKline
 
Sylvie Chabaud
No Relationships to Disclose
 
Laura Del Carpio
No Relationships to Disclose
 
Andrew Clamp
Consulting or Advisory Role - GlaxoSmithKline
Speakers' Bureau - GlaxoSmithKline
Research Funding - Advenchen Laboratories (Inst); Alkermes (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Eisai (Inst); Immunogen (Inst); Merck (Inst); MorphoSys (Inst); Pfizer (Inst); Verastem (Inst)
 
Gwenael Ferron
Employment - See2Cure
Consulting or Advisory Role - Abbvie; AstraZeneca; GlaxoSmithKline/Tesaro; MSD Oncology; Rand Biotech
Travel, Accommodations, Expenses - Abbvie; Eisai/MSD; GlaxoSmithKline; pharma&; PharmaMar; Rand Italy
 
Judith Kroep
Consulting or Advisory Role - AstraZeneca (Inst); Daiichi Sankyo Europe GmbH (Inst); GlaxoSmithKline (Inst); Immagene (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst); Philips Research (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH (Inst)
 
Alexandra Leary
Honoraria - Gerson Lehrman Group; Medscape; peervoice
Consulting or Advisory Role - Abbvie (Inst); Apmonia Therapeutics (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Merck Serono (Inst); MSD (Inst); PEGASCY; Pharmend (Inst); Seagen (Inst); Tesaro (Inst); zentalis (Inst)
Research Funding - Adaptimmune (Inst); AstraZeneca (Inst); Inivata (Inst); MSD Oncology (Inst); OSE Immunotherapeutics (Inst); owkin (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Oseimmuno; Tesaro
 
David Cibula
Consulting or Advisory Role - Abbvie; AstraZeneca; GlaxoSmithKline; Karyopharm Therapeutics; MSD; Roche
 
Frédéric Fiteni
Consulting or Advisory Role - AstraZeneca; Daiishi-Serono; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; Pfizer
 
Ilan Bruchim
No Relationships to Disclose
 
Hassan Serrier
No Relationships to Disclose
 
Susannah Catherine Carroll
No Relationships to Disclose
 
Anne-Sophie Belmont
No Relationships to Disclose
 
Julien Peron
Honoraria - Eisai Europe; Fab'entech
Research Funding - AstraZeneca/Merck (Inst)
 
Claire Chator
No Relationships to Disclose